In the context of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, TGFβ signaling in NSCs is disrupted (Krieglstein 2013) (von Bernhardi et al. 2015; Karampetsou et al. 2022). Here, TGFB1 is linked to Alzheimer disease.